Saturday, July 11, 2026

Drug profile · INN

tamsulosin

tamsulosin (APO-TAMSULOSIN SR) is a adrenergic receptor alpha-1 antagonist. Associated with Alphapharm Pty Ltd.

TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — tamsulosin

Quick answer

tamsulosin (APO-TAMSULOSIN SR) is a adrenergic receptor alpha-1 antagonist. Associated with Alphapharm Pty Ltd.

Key facts

INN tamsulosin
Brand APO-TAMSULOSIN SR
Mechanism Adrenergic receptor alpha-1 antagonist

Mechanism of action

Adrenergic receptor alpha-1 antagonist

Approval history

Authority Status Date
TGA approved
NMPA clinical trials

Pipeline programs

  1. NHL-014 Phase 3 · Chinese Academy of · Diffuse Large B-Cell Lymphoma
  2. TAMSU-12-24 Phase 1 · Anaxis Pharma · Benign prostatic hyperplasia (BPH)
  3. TAMSU-13-24 Phase 1 · Anaxis Pharma · Benign prostatic hyperplasia (BPH)
  4. Tamsulosin Phase 1 · Teva Pharma · Healthy
  5. Tamsulosin formulation-A Phase 1 · Chinese Academy of · Healthy
  6. Dutasteride plus tamsulosin Approved · GSK Glaxo Smith · Prostatic Hyperplasia
  7. Tamsulosin Oral Capsule Approved · First People's Hospital · Ischaemic Heart Disease (IHD)
  8. Tamsulosin Hydrochloride Unknown · Chinese Academy of · Benign Prostatic Hyperplasia

Frequently asked questions

What is tamsulosin?

tamsulosin (APO-TAMSULOSIN SR) is a adrenergic receptor alpha-1 antagonist. Associated with Alphapharm Pty Ltd.

What is the brand name for tamsulosin?

APO-TAMSULOSIN SR is a marketed brand name for tamsulosin. Check FDA Drugs@FDA for the current US label holder and prescribing information.